# Memo Therapeutics signs major collaboration with global biopharma company to advance immunoglobulin therapies

**Source**: https://bsse.ethz.ch/news-and-events/d-bsse-news/2026/02/memo-therapeutics-signs-major-collaboration-with-global-biopharma-company-to-advance-immunoglobulin-therapies.html
**Parent**: https://bsse.ethz.ch/news-and-events.html

On 9 February, the biotech company Memo Therapeutics announced a major strategic collaboration with CLS, a global developer in medicines that treat people with rare and serious diseases, to advance next-generation immunoglobulin (IgG) therapies. Development and commercial milestone payments may total up to CHF 265 million for the first product. Memo Therapeutics was founded in 2012, transferring technology from Sven Panke’s Bioprocess lab to the marketplace.

The agreement centres on Memo Therapeutics’ innovative recombinant polyclonal IgG technology, developed using its proprietary Dropzylla® platform. This technology enables the cloning of human antibody repertoires and the expression of recombinant polyclonal antibodies, with the goal of creating improved treatments for people with rare and serious diseases.

> “14 years ago we started the endeavour with less than CHF 200k from InnoSuisse. Today the company is a global leader in the discovery of fully humanized antibodies. This short development time was only possible thanks to an interdisciplinary approach.”
>
> Martin Held, Senior Scientist in the Bioprocess Lab, D-BSSE, and co-inventor of the technology in Memo Therapeutics

Find [external page media release](https://memo-therapeutics.com/2026/02/09/memo-therapeutics-ag-enters-into-a-collaboration-and-option-agreement-with-csl-for-development-of-recombinant-polyclonal-igg-technology/) and information about [external page Memo Therapeutics](https://memo-therapeutics.com) and its [external page Dropzylla IgG platform](https://memo-therapeutics.com/dropzylla/#igg-platform).

Learn about research in the [Bioprocess lab of Sven Panke](https://ethz.ch/content/specialinterest/bsse/bioprocess-lab/en).

Find all [companies that spun out of D-BSSE](/department/spin-offs).